Key result
KCNA1 pore mutations exerted loss-of-function effects associated with severe encephalopathy, whereas the p.A261T variant exhibited gain-of-function effects linked to mild focal epilepsy.
Why the study?
A wide phenotypic spectrum of neurological diseases is associated with KCNA1 (Kv1.1) variants, but the molecular basis and in vitro functional correlations remain unclear.
The study identifies a novel correlation between in vitro functional effects (gain- vs loss-of-function) of KCNA1 variants and clinical epilepsy severity, suggesting potential for targeted sodium channel inhibition in gain-of-function variants.
No takes yet. Share an insight, caveat, or question.
May guide precision therapies in KCNA1 epilepsy; hypothesis-generating from animal data, requiring human validation.
Miceli et al. (2021) studied KCNA1-related epilepsy (n=6). KCNA1 variants vs. Wild-type Kv1.1 subunits was evaluated on Functional properties of mutant Kv1.1 subunits (Kv1.1-mediated currents). KCNA1 pore mutations exerted loss-of-function effects associated with severe encephalopathy, whereas the p.A261T variant exhibited gain-of-function effects linked to mild focal epilepsy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: